HK1075364A1 - Inducible eukaryotic expression system - Google Patents

Inducible eukaryotic expression system

Info

Publication number
HK1075364A1
HK1075364A1 HK05106115.2A HK05106115A HK1075364A1 HK 1075364 A1 HK1075364 A1 HK 1075364A1 HK 05106115 A HK05106115 A HK 05106115A HK 1075364 A1 HK1075364 A1 HK 1075364A1
Authority
HK
Hong Kong
Prior art keywords
expression system
eukaryotic expression
inducible eukaryotic
inducible
expression
Prior art date
Application number
HK05106115.2A
Other languages
English (en)
Chinese (zh)
Inventor
James P Fandl
Changlin Dou
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of HK1075364A1 publication Critical patent/HK1075364A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HK05106115.2A 2002-05-29 2005-07-19 Inducible eukaryotic expression system HK1075364A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38400402P 2002-05-29 2002-05-29
PCT/US2003/016676 WO2003101189A1 (fr) 2002-05-29 2003-05-28 Systeme d'expression eucaryote inductible

Publications (1)

Publication Number Publication Date
HK1075364A1 true HK1075364A1 (en) 2005-12-16

Family

ID=29711966

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05106115.2A HK1075364A1 (en) 2002-05-29 2005-07-19 Inducible eukaryotic expression system

Country Status (11)

Country Link
US (2) US7455988B2 (fr)
EP (1) EP1531666B1 (fr)
JP (2) JP4817657B2 (fr)
AU (1) AU2003237259B2 (fr)
BR (1) BRPI0311201B1 (fr)
CA (1) CA2485939C (fr)
DK (1) DK1531666T3 (fr)
ES (1) ES2439874T3 (fr)
HK (1) HK1075364A1 (fr)
MX (1) MXPA04011679A (fr)
WO (1) WO2003101189A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1322771A2 (fr) * 2000-09-09 2003-07-02 BASF Plant Science GmbH SYSTEME INDUCTIBLE i TET /i MODIFIE PERMETTANT LA REGULATION DE L'EXPRESSION GENIQUE DANS DES PLANTES
US8673589B2 (en) 2002-05-29 2014-03-18 Regeneron Pharmaceuticals, Inc. Inducible eukaryotic expression system
JP4838722B2 (ja) 2003-10-24 2011-12-14 ゲンシア コーポレーション ポリヌクレオチドを送達する方法、及び送達用組成物
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
GB0418651D0 (en) * 2004-08-20 2004-09-22 Medical Res Council Method
IL296832A (en) * 2005-10-18 2022-11-01 Nat Jewish Health A process for making red blood cells using immortal hematopoietic stem cells and erythropoietin
DK2393927T3 (en) 2009-02-09 2015-03-30 Morphosys Ag Preparation of oligoclonal mixtures of antibodies in the individual cells
TW201823460A (zh) 2012-05-29 2018-07-01 美商再生元醫藥公司 生產細胞株增強子
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
US9388243B2 (en) 2013-05-29 2016-07-12 Samsung Electronics Co., Ltd. Method of target membrane protein depletion
TW202340452A (zh) 2015-08-04 2023-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
WO2017134137A1 (fr) * 2016-02-05 2017-08-10 Polygene Ag Système de régulation de gènes à base de glucocorticoïdes
KR20180134894A (ko) 2016-04-20 2018-12-19 리제너론 파마슈티칼스 인코포레이티드 발현 강화 유전자좌의 사용에 기초하여 항체를 만들기 위한 조성물 및 방법
CA3015389A1 (fr) 2016-04-20 2017-10-26 Regeneron Pharmaceuticals, Inc. Compositions et procedes de production d'anticorps bases sur l'utilisation de loci d'amelioration de l'expression
WO2022216825A1 (fr) * 2021-04-06 2022-10-13 Senti Biosciences, Inc. Mutants ert2 et leurs utilisations
IL307269A (en) * 2021-04-06 2023-11-01 Senti Biosciences Inc ERT2 mutations and their uses
IL312148A (en) * 2021-10-18 2024-06-01 Regeneron Pharma Controlled transcription of polynucleotides
WO2023167871A1 (fr) 2022-03-02 2023-09-07 Regeneron Pharmaceuticals, Inc. Procédé de fabrication d'anticorps à titre élevé

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833080A (en) * 1985-12-12 1989-05-23 President And Fellows Of Harvard College Regulation of eucaryotic gene expression
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US5096815A (en) * 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
US5756448A (en) * 1992-02-26 1998-05-26 The General Hospital Corporation Constitute activator of retinoid (CAR) receptor polypeptides
US5866755A (en) * 1993-06-14 1999-02-02 Basf Aktiengellschaft Animals transgenic for a tetracycline-regulated transcriptional inhibitor
US5814618A (en) * 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
AU684524B2 (en) * 1993-06-14 1997-12-18 Tet Systems Holding Gmbh & Co. Kg Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
GB2301991B (en) * 1995-06-06 1999-06-30 Plessey Telecomm SDH Network
US5739018A (en) * 1996-08-07 1998-04-14 The Regents Of The University Of California Packaging cell lines for pseudotyped retroviral vectors
US6133027A (en) * 1996-08-07 2000-10-17 City Of Hope Inducible expression system
US5972650A (en) * 1997-06-26 1999-10-26 Brigham And Women's Hospital Tetracycline repressor regulated mammalian cell transcription and viral replication switch
JP2003524368A (ja) * 1997-08-26 2003-08-19 アリアド ジーン セラピューティクス インコーポレイテッド ニ量化ドメイン、三量化ドメインまたは四量化ドメインおよび補足的非相同転写活性化ドメイン、転写抑制ドメイン、ｄｎａ結合ドメインまたはリガンド結合ドメインを含む融合蛋白
US6153383A (en) * 1997-12-09 2000-11-28 Verdine; Gregory L. Synthetic transcriptional modulators and uses thereof
FR2782732A1 (fr) * 1998-08-28 2000-03-03 Transgene Sa Systeme d'expression inductible
US7329728B1 (en) * 1999-10-25 2008-02-12 The Scripps Research Institute Ligand activated transcriptional regulator proteins
FR2814642B1 (fr) * 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
US6949379B2 (en) * 2000-10-20 2005-09-27 Canji, Inc. Aptamer-mediated regulation of gene expression
US20040102367A1 (en) * 2001-02-23 2004-05-27 Gage Fred H Gene expression system based on chimeric receptors
US7153685B2 (en) * 2002-03-11 2006-12-26 The Board Of Trustees Of The University Of Illinois Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells

Also Published As

Publication number Publication date
CA2485939A1 (fr) 2003-12-11
MXPA04011679A (es) 2005-03-07
AU2003237259B2 (en) 2008-01-24
CA2485939C (fr) 2013-10-29
EP1531666A4 (fr) 2006-05-24
JP2011152152A (ja) 2011-08-11
JP2005527227A (ja) 2005-09-15
BRPI0311201B1 (pt) 2017-08-08
US7514545B2 (en) 2009-04-07
JP4817657B2 (ja) 2011-11-16
US20030235886A1 (en) 2003-12-25
WO2003101189A1 (fr) 2003-12-11
DK1531666T3 (da) 2014-01-13
AU2003237259A1 (en) 2003-12-19
BRPI0311201B8 (fr) 2021-05-25
EP1531666A1 (fr) 2005-05-25
US20060107341A1 (en) 2006-05-18
ES2439874T3 (es) 2014-01-27
EP1531666B1 (fr) 2013-10-23
BR0311201A (pt) 2005-02-22
US7455988B2 (en) 2008-11-25

Similar Documents

Publication Publication Date Title
HK1075364A1 (en) Inducible eukaryotic expression system
GB0305444D0 (en) Parts list system
GB0305447D0 (en) Parts list system
GB0206995D0 (en) System
AU2003288976A8 (en) Trading system
AU2003299588A8 (en) Pipe-inspection system
GB0508835D0 (en) Annonymous trading system
GB0227952D0 (en) Messaging system
GB2389216B (en) Proximity system
PL371936A1 (en) Construction system
AU2003275368A8 (en) Prosthodontia system
AU2003226910A8 (en) Laser system
GB0225509D0 (en) E-maintenance system
AU2003295557A8 (en) Multiple-disks laser system
GB0204999D0 (en) Alarm system
GB0206994D0 (en) System
GB0206987D0 (en) System
GB0222962D0 (en) Laser system
PL352662A1 (en) Structural system
GB0513177D0 (en) Reply system
GB0214599D0 (en) Sprinkler system
GB0225092D0 (en) Polytunnel system
GB0211662D0 (en) System
IL161895A0 (en) Gateway system
GB0220163D0 (en) Winningnote system

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: ADDITION OF INVENTOR: DOU, CHANGLIN

PE Patent expired

Effective date: 20230527